Key clinical point: The updated ThroLy scoring system had a high negative predictive value for thromboembolic events in lymphoma patients.
Major finding: The updated ThroLy had a positive predictive value of 22%-25%, a negative predictive value of 96%, sensitivity of 56%-57%, and specificity of 85%-87%.
Study details: The scoring system was validated on 1,723 lymphoma patients treated at eight institutions worldwide.
Disclosures: Dr. Antic reported having no conflicts of interest.
Leukemia and Lymphoma 2018, Dubrovnik, Croatia